课题基金 / 基金详情

PROSTATE, LUNG, COLORECTAL, AND OVARIAN (PLCO) CANCER

PROSTATE, LUNG, COLORECTAL, AND OVARIAN (PLCO) CANCER
前列腺癌、肺癌、结直肠癌和卵巢癌 (PLCO)
批准号:
6340001
负责人:
DAVID S. CHIA
金额:
$58.43万
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-09-30 至 2006-09-29

项目成果

DAVID S. CHIA的其他基金

相似基金

相关文献

期刊论文(14)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1158/0008-5472.can-11-3194
发表时间: 2012-02-01
期刊: Cancer research
影响因子: 11.2
作者: [Leng S, Stidley CA, Liu Y, Edlund CK, Willink RP, Han Y, Landi MT, Thun M, Picchi MA, Bruse SE, Crowell RE, Van Den Berg D, Caporaso NE, Amos CI, Siegfried JM, Tesfaigzi Y, Gilliland FD, Belinsky SA]
通讯作者: Belinsky SA
Breastfeeding experience and breast cancer risk among postmenopausal women.
绝经后妇女的母乳喂养经历和乳腺癌风险。
DOI: --
发表时间: 1998
期刊: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
影响因子: --
作者: [Enger,SM, Ross,RK, Paganini-Hill,A, Bernstein,L]
通讯作者: Bernstein,L
Body size, physical activity, and breast cancer hormone receptor status: results from two case-control studies.
体型、体力活动和乳腺癌激素受体状态:两项病例对照研究的结果。
DOI: --
发表时间: 2000
期刊: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
影响因子: --
作者: [Enger,SM, Ross,RK, Paganini-Hill,A, Carpenter,CL, Bernstein,L]
通讯作者: Bernstein,L
Flexible sigmoidoscopy in the randomized prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial: added yield from a second screening examination.
随机前列腺癌、肺癌、结直肠癌和卵巢癌 (PLCO) 癌症筛查试验中的柔性乙状结肠镜检查:第二次筛查检查的产量增加。
DOI: 10.1093/jnci/djr549
发表时间: 2012
期刊: Journal of the National Cancer Institute
影响因子: --
作者: [Weissfeld,JoelL, Schoen,RobertE, Pinsky,PaulF, Bresalier,RobertS, Doria-Rose,VPaul, Laiyemo,AdeyinkaO, Church,Timothy, Yokochi,LanceA, Yurgalevitch,Susan, Rathmell,Joshua, Andriole,GeraldL, Buys,Saundra, Crawford,EDavid, Fouad,Mona, ]
通讯作者:
6
    Advancing EFIRM-Liquid Biopsy (eLB) to a CLIA-Certified Laboratory Developed Test (eLB-LDT) for Detection of Actionable EGFR Mutations in NSCLC Patients
    Advancing EFIRM-Liquid Biopsy (eLB) to a CLIA-Certified Laboratory Developed Test (eLB-LDT) for Detection of Actionable EGFR Mutations in NSCLC Patients
    BIOMARKERS VALIDATION LABORATORIES
    BIOMARKERS VALIDATION LABORATORIES
    国内基金
    海外基金
    胚胎脑发育的分子机理:lgl2(late gestation lung 2)蛋白质的生物学功能的研究
    • 批准号:
      30470854
    • 项目类别:
      面上项目
    • 资助金额:
      18.0万元
    • 批准年份:
      2004
    • 负责人:
      陶涛
    • 依托单位: